• IWP-2 in Disease Microenvironment Modeling: Beyond Cancer Re

  2026-05-16

  Explore how IWP-2, a powerful Wnt production inhibitor, enables advanced modeling of disease microenvironments beyond oncology. Uncover mechanistic insights, protocol best practices, and new perspectives for translational scientists.

• Hematoxylin and Eosin Staining Kit: Practical Research Guide

  2026-05-15

  The Hematoxylin and Eosin Staining Kit (SKU: K1142) offers ready-to-use solutions for reliable visualization of tissue and cellular morphology in histopathological and cytological research. It is optimized for staining paraffin-embedded and frozen tissue sections, but is not designed for diagnostic or clinical decision-making. Researchers benefit from standardized reagents and consistent results in non-clinical applications.

• Evaluating Tissue Marking Dyes for Small Biopsy Preservation

  2026-05-15

  This study investigates the effectiveness of various dyes—including hematoxylin and alcian blue—for marking small tissue biopsies during routine pathology processing. The findings highlight hematoxylin as the preferred dye for enhancing tissue visibility and retention, with implications for improving diagnostic accuracy in histopathology laboratories.

• ABT-199 (Venetoclax): Precision Bcl-2 Inhibition in Apoptosi

  2026-05-14

  Explore the unique advantages of ABT-199 (Venetoclax) as a potent, selective Bcl-2 inhibitor for apoptosis assays in hematologic malignancy research. This article offers a deeper, protocol-centric analysis and interprets the latest epigenetic findings for informed assay design.

• Competitive CD40–STING–TRAF2 Binding Drives IRF4 B Cell Acti

  2026-05-14

  This study uncovers how competitive binding between CD40 and STING to TRAF2 regulates IRF4-mediated B cell activation within tertiary lymphoid structures (TLS) in esophageal squamous cell carcinoma (ESCC). The findings highlight the prognostic value of TLS and elucidate a mechanism linking innate immune signaling to antitumor B cell responses, offering new directions for biomarker and immunotherapy research.

• Heparin Sodium (SKU A5066): Reliable Anticoagulant for Resea

  2026-05-13

  This scenario-driven article addresses laboratory challenges in cell viability and coagulation assays, demonstrating how Heparin sodium (SKU A5066) from APExBIO enables reproducible, sensitive, and workflow-compatible results. Drawing on literature-backed data, the article guides biomedical researchers through practical problem-solving, protocol optimization, and informed product selection to enhance experimental reliability.

• MOG (35-55) Peptide: Driving Translational Innovation in Neu

  2026-05-13

  Explore how APExBIO's MOG (35-55) Peptide is redefining experimental autoimmune encephalomyelitis (EAE) modeling through rigorous mechanistic insight, translational strategy, and integration of emerging regulatory pathways such as PARP7-mediated interferon signaling. This thought-leadership piece offers actionable guidance for researchers seeking to bridge bench and bedside in multiple sclerosis and neuroinflammation research.

• Prochlorperazine: Mechanisms and Momentum in Melanoma Resear

  2026-05-12

  This thought-leadership article explores Prochlorperazine’s evolving role from a dopamine D2 receptor antagonist and antiemetic agent to a multifaceted tool in melanoma research. We synthesize mechanistic insights, experimental benchmarks, and translational guidance for researchers, with a focus on evidence-backed parameters and strategic positioning within the competitive landscape. The narrative is anchored in landmark studies and APExBIO’s commitment to quality, providing a roadmap for informed experimental design and future innovation.

• EZ Cap™ Human PTEN mRNA (ψUTP): Applied Workflows & Troubles

  2026-05-12

  Leverage EZ Cap™ Human PTEN mRNA (ψUTP) for next-generation cancer research, enabling precise PI3K/Akt pathway inhibition and robust gene expression. This guide details experimental workflows, protocol optimization, and troubleshooting strategies, translating recent nanoparticle-mediated mRNA delivery breakthroughs into actionable laboratory protocols.

• Astragaloside IV Inhibits Pituitary Tumor Proliferation via

  2026-05-11

  This study reveals that Astragaloside IV suppresses pituitary tumor cell growth by targeting TUBB4B, leading to regulation of the STMN1/ERK signaling pathway and enhanced apoptosis. These mechanistic insights provide a foundation for novel molecular-targeted therapies and refine cell proliferation assay strategies in neuro-oncology research.

• SLC11A1 Drives TGF-β1 Pathway to Resist Ferroptosis in CRC

  2026-05-11

  This study uncovers how SLC11A1 overexpression activates the TGF-β1 signaling pathway, conferring resistance to ferroptosis and promoting colorectal cancer cell proliferation and invasion. The findings reveal a new mechanistic link between SLC11A1 and ferroptosis suppression, highlighting potential therapeutic strategies for colorectal cancer.

• Iptacopan Monotherapy in PNH: Clinical Efficacy and Research

  2026-05-10

  This proof-of-concept phase 2 study demonstrates that oral Iptacopan (LNP023) monotherapy produces rapid, durable suppression of hemolysis and significant improvements in hemoglobin and transfusion independence in paroxysmal nocturnal hemoglobinuria (PNH). The findings validate alternative pathway factor B inhibition as a promising therapeutic strategy and provide a basis for translational research in complement-mediated disorders.

• Dual Terminal Oxidase Inhibition: Advancing Tuberculosis Reg

  2026-05-09

  This study demonstrates that pretomanid, a bicyclic nitroimidazole derivative, exerts its bactericidal effect against Mycobacterium tuberculosis by simultaneously inhibiting both major respiratory terminal oxidases. These findings provide a mechanistic basis for rational drug combinations that enhance efficacy and suppress resistance in tuberculosis therapy.

• Computational Hapten Design Enables Dual Detection of Mushro

  2026-05-09

  This study introduces a computational chemistry-based approach for designing haptens, enabling highly sensitive, simultaneous detection of amatoxins and phallotoxins in mushrooms. The resulting dual-target fluorescent immunochromatographic assay addresses a critical need for rapid, on-site toxin detection, with significant implications for public health and toxicology research.

• Atrial Natriuretic Peptide (ANP), Rat: Precision Tools for M

  2026-05-08

  Explore the nuanced role of Atrial Natriuretic Peptide (ANP) in cardiovascular research, with a focus on experimental optimization and translational insight. This article provides advanced protocol guidance and practical differentiation for ANP peptide hormone applications.

406 records 15/28 page Previous Next First page 上5页 1112131415 下5页 Last page